News
F or the last few months, not a day has gone by where tariffs haven’t been on the tip of everyone’s tongue. The economic ...
Ozempic is massively threatening the established diet industry — and it appears that Weight Watchers is now getting the ...
WeightWatchers has filed for bankruptcy in the US as it struggles with debt and fierce competition from fat-loss jabs like ...
The diet company known as WeightWatchers filed for bankruptcy saying its 62-year-old business model was now under threat amid ...
The maker of Ozempic and Wegovy expects lower sales and profit growth this year despite recent victories against compounders.
Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies. Compare side effects here.
The famed US diet company originally known as WeightWatchers said it has filed for bankruptcy but will continue operations ...
WeightWatchers, the 62-year-old program that revolutionized dieting for millions of people around the world, has filed for ...
The FDA in February formally declared the end of the semaglutide shortage, which Novo Nordisk expects will help improve the ...
Stock futures rose on Wednesday on optimism around trade talks with China. Treasury Secretary Scott Bessent and Trade Representative Jamieson Greer are slated to meet with Chinese officials for the ...
Novo Nordisk cut 2025 sales forecast citing competition from compounded versions of its Wegovy weight-loss drug. Invezz takes ...
U.S. trade policy has also heightened investor concerns over the potential impact to Novo Nordisk's key market. U.S. President Trump has threatened to unveil tariffs on pharmaceutical products in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results